tiprankstipranks
Advertisement
Advertisement
Treace Medical Shareholders Back Directors, Pay and Auditor
PremiumCompany AnnouncementsTreace Medical Shareholders Back Directors, Pay and Auditor
3M ago
Treace Medical participates in a conference call with BTIG
Premium
The Fly
Treace Medical participates in a conference call with BTIG
3M ago
Treace Medical backs FY26 revenue view $202M-$212M, consensus $205.92M
Premium
The Fly
Treace Medical backs FY26 revenue view $202M-$212M, consensus $205.92M
3M ago
Treace Medical price target lowered to $2 from $3 at Truist
PremiumThe FlyTreace Medical price target lowered to $2 from $3 at Truist
5M ago
Treace Medical price target lowered to $2.25 from $2.50 at UBS
Premium
The Fly
Treace Medical price target lowered to $2.25 from $2.50 at UBS
5M ago
Treace Medical price target lowered to $7 from $7.50 at Lake Street
Premium
The Fly
Treace Medical price target lowered to $7 from $7.50 at Lake Street
5M ago
Treace Medical sees Q4 revenue $62.1M-$62.5M, consensus $61.76M
PremiumThe FlyTreace Medical sees Q4 revenue $62.1M-$62.5M, consensus $61.76M
7M ago
Treace Medical anticipates ‘continued positive procedure volume growth’
Premium
The Fly
Treace Medical anticipates ‘continued positive procedure volume growth’
7M ago
Treace Medical reports completion of first Lapiplasty Lightning technology case
Premium
The Fly
Treace Medical reports completion of first Lapiplasty Lightning technology case
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100